Insider · CIK 0001944813
Catalina Valencia
Files at AXIM (AXIM BIOTECHNOLOGIES, INC.). First filing -, latest -.
Catalina Valencia files SEC Form 4 as president, director and 10% owner at AXIM (AXIM BIOTECHNOLOGIES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Catalina Valencia has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 30, 2024 | AXIM AXIM BIOTECHNOLOGIES, INC. | POpen-market purchase Common Stock | +1,086,216 | - | - | 28,608,220 | Oct 15, 2024 |
Questions about Catalina Valencia
Answered from the filings on this page, as of the latest one.
Is Catalina Valencia buying or selling?
Catalina Valencia has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Catalina Valencia's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Catalina Valencia has 0.
Where does Catalina Valencia file Form 4?
Catalina Valencia has filed Form 4 at AXIM (AXIM BIOTECHNOLOGIES, INC.) as President and Director. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.